Regencell Bioscience Holdings RGC
NASDAQ RGC
$6.20 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Regencell Bioscience Holdings (RGC) Enterprise Value (2022 - 2025)

Updated

Regencell Bioscience Holdings (RGC) recorded Enterprise Value of $270.91 million in the quarter ended Dec 31, 2025.

Analysis

Regencell Bioscience Holdings (RGC) Enterprise Value (2022 - 2025) Analysis & Trends

On a TTM basis, Regencell Bioscience Holdings' Enterprise Value came in at $266.49 million as of Dec 31, 2025; for the year ended Jun 30, 2025, it was $216.84 million.

  • Across earlier years, Enterprise Value came in at -$6.79 million in the year ended Jun 30, 2024, $16.33 million in the year ended Jun 30, 2023 and -$4.56 million in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Regencell Bioscience Holdings 80.68 Mn 73.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 270.91 Mn
Jun 30, 2025 216.84 Mn
Jun 30, 2024 -6.79 Mn
Jun 30, 2023 16.33 Mn
Jun 30, 2022 -4.56 Mn
API Access

Regencell Bioscience Holdings Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=RGC&period=max&api_key=YOUR_API_KEY